Suchergebnisse - "Ling, Yun"

PubPharm (45)

1

A randomized trial of Bacteroides fragilis 839 on preventing chemotherapy-induced myelosuppression and gastrointestinal adverse effects in breast cancer patients

enthalten in: Asia Pacific journal of clinical nutrition | 2024

von Zeng, T. | Deng, Y. | Lin, C. | +7

2

Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K/mTOR dual inhibitor for the treatment of acute myeloid leukemia

enthalten in: European journal of medicinal chemistry | 2023

von Yang, C. | Chen, Y. | Wu, T. | +8

3

Discovery of a photosensitizing PI3K inhibitor for tumor therapy : Design, synthesis and in vitro biological evaluation

enthalten in: Bioorganic & medicinal chemistry letters | 2023

von Yang, C. | Gong, Y. | Deng, M. | +3

4

Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128/Glu171

enthalten in: European journal of medicinal chemistry | 2023

von Xiang, R. | Lu, M. | Wu, T. | +9

5

Design, synthesis and in vitro biological evaluation of 2-aminopyridine derivatives as novel PI3Kδ inhibitors for hematological cancer

enthalten in: Bioorganic & medicinal chemistry letters | 2023

von Yang, C. | Gong, Y. | Gao, Y. | +6

6

Development of anti-breast cancer PI3K inhibitors based on 7-azaindole derivatives through scaffold hopping : Design, synthesis and in vitro biological evaluation

enthalten in: Bioorganic chemistry | 2021

von Yang, C. | Lu, M. | Chen, Y. | +8

7

Discovery of cinnoline derivatives as potent PI3K inhibitors with antiproliferative activity

enthalten in: Bioorganic & medicinal chemistry letters | 2021

von Tian, C. | Yang, C. | Wu, T. | +8

8

Cytotoxic p-terphenyls from the deep-sea-derived Aspergillus candidus

enthalten in: Natural product research | 2021

von Lin, Y. | Xie, C. | Xing, C. | +6

9

Preparation and identification of an anti-idiotypic antibody antagonist (FG8) for EGFR that shows potential activity against liver cancer cells

enthalten in: Biotechnology letters | 2021

von Wang, Y. | He, F. | Zhang, H. | +4

10

Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways : a promising insight into cancer treatment

enthalten in: Experimental & molecular medicine | 2021

von Lv, D. | Zhou, L. | Tang, H.

1
2
3
4
5
Nächster »
[5]